Mesoblast Limited Analysis
| Analyst Ratings |
|
Average Target Price
|
10.63
|
|
Average Rating
|
3.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.17
|
0.00
|
0.17
|
100.00%
|
|
2022-12-31
|
-0.20
|
0.00
|
0.20
|
100.00%
|
|
2022-09-30
|
-0.16
|
-0.12
|
0.04
|
25.00%
|
|
2022-06-30
|
-0.10
|
-0.17
|
-0.07
|
-70.00%
|
|
2022-03-31
|
-0.13
|
-0.16
|
-0.03
|
-23.08%
|
|
2021-12-31
|
-0.13
|
-0.20
|
-0.07
|
-53.85%
|
|
2021-09-30
|
-0.13
|
-0.17
|
-0.04
|
-30.77%
|
|
2021-06-30
|
-0.08
|
-0.17
|
-0.09
|
-112.50%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.12
|
|
2022-06-30
|
-0.70
|
|
2021-06-30
|
-0.82
|
|
2020-06-30
|
-0.74
|
|
2019-06-30
|
-0.91
|
|
2018-06-30
|
-0.37
|
|
2017-06-30
|
-0.96
|
|
2016-06-30
|
-0.09
|
|
2015-06-30
|
0.00
|